J. Goldman & CO LP Boston Scientific Corp Transaction History

J. Goldman & CO LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$57.6 - $68.62 $436,204 - $519,659	-7,573 Reduced 25.23%	22,440 $1.54 Million
Q4 2023 Feb 14, 2024	BUY	$48.64 - $57.81 $704,550 - $837,377	14,485 Added 93.28%	30,013 $1.74 Million
Q3 2023 Nov 14, 2023	BUY	$50.19 - $54.68 $779,350 - $849,071	15,528 New	15,528 $819,000
Q2 2020 Aug 14, 2020	SELL	$30.19 - $39.11 $3.25 Million - $4.2 Million	-107,514 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$25.83 - $45.71 $1.59 Million - $2.82 Million	-61,726 Reduced 36.47%	107,514 $3.51 Million
Q4 2019 Feb 14, 2020	BUY	$37.87 - $45.37 $1.31 Million - $1.57 Million	34,664 Added 25.76%	169,240 $7.65 Million
Q3 2019 Nov 14, 2019	SELL	$40.31 - $43.45 $687,930 - $741,517	-17,066 Reduced 11.25%	134,576 $5.48 Million
Q2 2019 Aug 14, 2019	SELL	$34.91 - $42.98 $9.54 Million - $11.7 Million	-273,210 Reduced 64.31%	151,642 $6.52 Million
Q1 2019 May 14, 2019	BUY	$32.91 - $40.75 $8.95 Million - $11.1 Million	271,971 Added 177.9%	424,852 $16.3 Million
Q4 2018 Feb 14, 2019	BUY	$31.73 - $39.04 $4.85 Million - $5.97 Million	152,881 New	152,881 $5.4 Million

1,537

1.19B

6.79M

10.1M

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $125B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.